| Naslov: | Real-world data on the minimed 780G advanced hybrid closed-loop system use during type 1 diabetes pregnancy : one centre observational study |
|---|
| Avtorji: | ID Munda, Ana (Avtor)
ID Kovacic, Chiara (Avtor)
ID Pongrac Barlovič, Draženka (Avtor) |
|---|
| Datoteke: |  PDF - Predstavitvena datoteka, prenos (822,80 KB)
MD5: A0B837434E99FDA037C794FF7E59A763
 URL - Izvorni URL, za dostop obiščite https://www.sciencedirect.com/science/article/pii/S1056872724001211
|
|---|
| Jezik: | Angleški jezik |
|---|
| Tipologija: | 1.01 - Izvirni znanstveni članek |
|---|
| Organizacija: |  UKC LJ - Univerzitetni klinični center Ljubljana
|
|---|
| Povzetek: | Aim The efficacy of hybrid closed-loop systems (HCLs) in managing glycemic control in pregnant women with type 1 diabetes remains inadequately characterized. We evaluated the use of the Medtronic Minimed 780G HCLs. Methods: The retrospective observational study analyzed the glycemic and perinatal outcomes of pregnant women using the HCLs, followed at our tertiary centre. Independent t-tests were employed to compare data among trimesters based on pre-pregnancy HbA1c. The associations between glycemic parameters and perinatal outcomes were explored using Spearman rho. Results: Among the 21 women (age: 33.5 ± 4.2 years, diabetes duration: 21.2 ± 7.6 years, pre-pregnancy HbA1c 7.0 ± 1.1 % (52.9 ± 11.9 mmol/mol)) time in range (pTIR, 63–140 mg/dl; 3.5–7.8 mmol/l) increased progressively throughout pregnancy (trimesters: first: 64.0 ± 9.0 %; second:71.3 ± 11.8 %; third: 75.7 ± 8.1 %). Simultaneously, mean sensor glucose decreased (trimesters: first: 130 ± 10.4 mg/dl (7.2 ± 0.6 mmol/l); second: 120.9 ± 13.4 mg/dl (6.7 ± 0.7 mmol/l); third: 117.3 ± 9.1 mg/dl (6.5 ± 0.5 mmol/l)). Although a majority of women achieved the target pTIR until the third trimester, this did not consistently prevent the delivery of a largefor-gestational-age baby. Notably, one ketoacidosis event occurred, and there were no reported instances of severe hypoglycemia. Conclusion: Use of the Minimed 780G HCLs enabled the attainment of recommended pregnancy glycemic targets for most women with type 1 diabetes in a real-world setting. |
|---|
| Ključne besede: | Type 1 diabetes, pregnancy continuous glucose monitoring, closed-loop insulin delivery |
|---|
| Status publikacije: | Objavljeno |
|---|
| Verzija publikacije: | Objavljena publikacija |
|---|
| Leto izida: | 2024 |
|---|
| Št. strani: | str. 1-7 |
|---|
| Številčenje: | Vol. 38, iss. 8, [article no.] 108795 |
|---|
| PID: | 20.500.12556/DiRROS-30020  |
|---|
| UDK: | 616.379 |
|---|
| ISSN pri članku: | 1873-460X |
|---|
| DOI: | 10.1016/j.jdiacomp.2024.108795 |
|---|
| COBISS.SI-ID: | 200991491 |
|---|
| Opomba: | Nasl. z nasl. zaslona;
Opis vira z dne 8. 7. 2024;
|
|---|
| Datum objave v DiRROS: | 11.06.2026 |
|---|
| Število ogledov: | 127 |
|---|
| Število prenosov: | 134 |
|---|
| Metapodatki: |    |
|---|
|
:
|
Kopiraj citat |
|---|
| | | | Objavi na: |  |
|---|
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše
podrobnosti ali sproži prenos. |
